首站-论文投稿智能助手
典型文献
Research Progress on the Pharmacological Mechanisms of Chinese Medicines that Tonify Qi and Activate Blood Against Cerebral Ischemia/Reperfusion Injury
文献摘要:
Cerebral ischemia?reperfusion injury (CIRI) refers to a pathological phenomenon that aggravates the injury after the restoration of blood perfusion and oxygen supply to the cerebral ischemia?induced tissues and organs, with a relatively high incidence. The traditional Chinese medicine (TCM) believes that Qi deficiency and blood stasis are the cause of CIRI. Therefore, Chinese medicine for tonifying Qi and activating blood is regarded as an important choice for the treatment of CIRI. In recent years, it has been found that many Chinese herbal medical ingredients and compound Chinese medicine (CCM) have significant anti?CIRI effects, and their mechanisms of action mainly include improving brain blood supply, neuroprotection, regulating signal pathways such as TLR4/HO?1/Bcl?2, protecting mitochondrial function, regulating related protein levels, and regulating oxidative molecule levels. This article summarizes and introduces the pharmacological mechanisms of Tonifying?Qi and activating?blood Chinese medicine and CCM which have the function of anti?CIRI. Our goal is to provide effective reference for further researches on the cerebral protection of related TCMs or compounds and their clinical application.
文献关键词:
作者姓名:
Xiao?Yu Zheng;Ye?Hao Zhang;Wen?Ting Song;Dennis Chang;Jian?Xun Liu
作者机构:
Beijing University of Chinese Medicine,Graduate School,Beijing 100029;Institute of Basic Medical Sciences of Xiyuan Hospital,China Academy of Chinese Medical Sciences,Beijing Key Laboratory of Pharmacology of Chinese Materia,Beijing 100091,China;NICM Health Research Institute,Western Sydney University,Westmead,NSW 2751,Australia
引用格式:
[1]Xiao?Yu Zheng;Ye?Hao Zhang;Wen?Ting Song;Dennis Chang;Jian?Xun Liu-.Research Progress on the Pharmacological Mechanisms of Chinese Medicines that Tonify Qi and Activate Blood Against Cerebral Ischemia/Reperfusion Injury)[J].世界中医药杂志(英文版),2022(02):225-235
A类:
Tonify,Tonifying
B类:
Research,Progress,Pharmacological,Mechanisms,Chinese,Medicines,that,Qi,Activate,Blood,Against,Cerebral,Ischemia,Reperfusion,Injury,ischemia,reperfusion,injury,CIRI,refers,pathological,phenomenon,aggravates,after,restoration,blood,oxygen,supply,cerebral,induced,tissues,organs,relatively,high,incidence,traditional,medicine,believes,deficiency,stasis,are,cause,Therefore,tonifying,activating,regarded,important,choice,treatment,recent,years,has,been,found,many,herbal,medical,ingredients,CCM,have,significant,anti,effects,their,mechanisms,action,mainly,include,improving,brain,neuroprotection,regulating,signal,pathways,such,TLR4,HO,Bcl,protecting,mitochondrial,function,related,protein,levels,oxidative,molecule,This,article,summarizes,introduces,pharmacological,which,Our,goal,provide,effective,reference,further,researches,TCMs,compounds,clinical,application
AB值:
0.61169
相似文献
Guben Tongluo Formula Protects LPS-induced Damage in Lamina Propria B Lymphocytes Through TLR4/MyD88/NF-κB Pathway
Qing WU;Wei MENG;Jiao-jiao SHEN;Jia-yuan BAI;Luo-bing WANG;Ting-yu LIANG;Di HUANG;Pei-cheng SHEN-Department of Nephrology,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Department of Clinical Laboratory,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Department of Nursing,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai201203,China;Department of Pathology,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Key Laboratory of Liver and Kidney Diseases,Shanghai 201203,China;Key Laboratory of Liver and Kidney Diseases(Shanghai University of Traditional Chinese Medicine),Ministry of Education,Shanghai 201203,China;Shanghai Key Laboratory of Traditional Chinese Clinical Medicine(20DZ2272200),Shanghai 201203,China
Effcacy-oriented compatibility for Tianma(Rhizoma Gastrodiae),Yanlingcao(Trillium tschonoskii Maxim)and Bingpian(Borneolum Syntheticum)on improving cerebral ischemia stroke by network pharmacology and serum pharmacological methods
LI Zhiyong;ZHU Na;LI Jianliang;FENG Liang;JIANG Yanyan;LI Caifeng;LIN Ling;HUANG Xiulan-Postdoctoral mobile station of environmental biology,Faculty of Life Science and Technology,Kunming University of Science and Technology,Kunming,Yunnan 650500,China;Center for Analytical Chemistry of Chinese Materia Medica,Institute of Chinese Materia Medica,China Academy of Chinese Medical Sciences,Beijing 100700,China;Pharmacological Department,School of Pharmacy,Minzu University of China,Beijing,100081,China;Aerosol preparation research center,Institute of Chinese Materia Medica,China Academy of Chinese Medical Sciences,Beijing 100700,China;School of Traditional Chinese Pharmacy,China Pharmaceutical University,Nanjing,Jiangsu 211198,China;Department of Chinese Materia Medica Chemistry,School of Chinese Materia Medica,Beijing University of Chinese Medicine,Beijing,102488,China;Academician work station,Jiangxi University of Traditional Chinese Medicine,Nanchang,Jiangxi,330004,China
Buyang Huanwu Tang(补阳还五汤)protects H202-induced RGC-5 cell against oxidative stress and apoptosis via reactive oxygen species-mitogen-activated protein kinase signaling pathway
ZHENG Wei;WANG Mingxing;LIU Shanxue;LUAN Chao;ZHANG Yanqiu;XU Duoduo;WANG Jian-Department of Ophthalmology,First Affiliated Hospital,Changchun University of Chinese Medicine,Changchun 130021,China;Department of Experimental Center,First Affiliated Hospital,Changchun University of Chinese Medicine,Changchun 130021,China;Changchun University of Chinese Medicine,Changchun 130117,China;Pharmaceutical Department,First Affiliated Hospital,Changchun University of Chinese Medicine,Changchun 130021,China;College of Pharmacy,Changchun University of Chinese Medicine,Changchun 130117,China;Department of Encephalopathy Center,First Affiliated Hospital,Changchun University of Chinese Medicine,Changchun 130021,China
Pathological Change of Chronic Hepatitis B Patients with Different Tongue Coatings by Circular Multi-omics Integrated Analysis
TANG Yi-shuang;GUO Jian-chun;XU Lin;ZHANG Xiao-na;SHEN Xiao-ping;HAI Ya-mei;MAO Yu-feng;HU Yi-yang;ZHAO Yu-Key Laboratory of Liver and Kidney Diseases,Institute of Liver Diseases,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203 ,China;Department of Integrated Chinese and Western Medicine,Hangzhou Xixi Hospital,Hangzhou 310023 ,China;National Engineering Center for Biochip at Shanghai,Shanghai 201203 ,China;Institute of Clinical Pharmacology,Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203 ,China;Shanghai Key Laboratory of Traditional Chinese Clinical Medicine,Shanghai 201203 ,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。